Calcium channel blockade in experimental aminoglycoside nephrotoxicity

Area of Science:

• Nephrology
• Pharmacology
• Toxicology

Background:

• Calcium channel blockers (CCBs) show protective effects in ischemic acute renal failure.
• Potential mechanisms include preventing calcium influx and vasodilation, improving renal blood flow.
• Aminoglycosides are known nephrotoxic agents, causing renal insufficiency and tissue damage.

Purpose of the Study:

• To investigate the effect of verapamil treatment on renal insufficiency and calcium accumulation following aminoglycoside administration.
• To determine if verapamil can mitigate gentamicin-induced nephrotoxicity in a rat model.

Main Methods:

• Rats were administered gentamicin (120 mg/kg/day) for six or nine days.
• Verapamil was administered in drinking water (10 mg/100 cc) to a treatment group.
• Control animals received gentamicin without verapamil.
• Renal function (creatinine clearance) and cortical tissue calcium accumulation were assessed.

Main Results:

• No significant difference in functional damage or cortical tissue calcium accumulation was observed between verapamil-treated rats and control animals.
• Gentamicin administration led to reduced creatinine clearance and increased tissue calcium.
• Tissue calcium accumulation correlated with the reduction in creatinine clearance.

Conclusions:

• Verapamil treatment did not prevent or reduce renal insufficiency or calcium accumulation induced by gentamicin.
• The findings suggest that verapamil is not protective against aminoglycoside-induced nephrotoxicity in this model.
• Tissue calcium accumulation appears to be a marker of lethal tubular cell injury in aminoglycoside nephrotoxicity.